Phase 4 Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older (male or female)
- You have been diagnosed with moderate to severe eczema (atopic dermatitis), confirmed by specific measurement scores checked at the start of the trial — including a skin severity score (EASI) of 16 or higher, a doctor's overall rating (IGA) of 3 or higher, and eczema covering 10% or more of the body
Who may not be able to join:
- You have previously used the medication dupilumab (also known by the brand name Dupixent)
- You have a known or suspected allergy to dupilumab or any of its ingredients
- You have a history of being unusually sensitive to sunlight or light exposure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 6094434500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Investigators Global Assessment Score of score of 0 or 1
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.